Möglichkeiten und Grenzen einer ambulanten Antibiotikatherapie der infektiösen Endokarditis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-09

AUTHORS

Michael Ritter, Peter Alter, Bernhard Maisch

ABSTRACT

BACKGROUND: Infective endocarditis has a high morbidity and lethality. Therefore antibiotic treatment has to be intravenous to achieve high blood levels and has to last several weeks without an interruption of treatment at the weekends. PATIENT SELECTION FOR OUTPATIENT THERAPY: It is therefore crucial to select the patient group that is suited for an outpatient, antibiotic therapy very carefully. In general only hemodynamically stable patients without complications in whom the responsible organism has been identified should be considered. TREATMENT: From a pharmacological point of view intravenous or intramuscular application for the complete duration of therapy is obligatory. Endocarditis caused by penicillin-susceptible streptococci, the biggest group of organisms responsible for endocarditis, can be treated with Ceftriaxon once daily for 4 weeks. For other organisms there are at present no data available which support the feasibility of an outpatient therapy. In particular antibiotic therapy with a complex regimen for those organisms is not practicable for outpatient usage. Possibly, in the near future computer controlled pumps might overcome this disadvantage. LIMITS: Every outpatient therapy should be initiated under inpatient conditions and only after an initial response to the antibiotic therapy continued in an outpatient setting. Today reliable outpatient therapy and follow-up 7 days a week under the given outpatient infrastructure is problematic and remains an exception. However, considering cost-effectiveness outpatient as compared to inpatient antibiotic therapy could be an interesting economically advantageous alternative. More... »

PAGES

418-423

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/pl00002045

DOI

http://dx.doi.org/10.1007/pl00002045

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007485680

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11683072


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ceftriaxone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cephalosporins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Echocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endocarditis, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intramuscular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Outpatients", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Compliance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Streptococcal Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Ritter", 
        "givenName": "Michael", 
        "id": "sg:person.0700231510.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700231510.25"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Alter", 
        "givenName": "Peter", 
        "id": "sg:person.01065373312.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065373312.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Klinik f\u00fcr Innere Medizin \u2013 Kardiologie, Herzzentrum der Philipps-Universit\u00e4t Marburg, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maisch", 
        "givenName": "Bernhard", 
        "id": "sg:person.0630132362.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630132362.75"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001-09", 
    "datePublishedReg": "2001-09-01", 
    "description": "BACKGROUND: Infective endocarditis has a high morbidity and lethality. Therefore antibiotic treatment has to be intravenous to achieve high blood levels and has to last several weeks without an interruption of treatment at the weekends.\nPATIENT SELECTION FOR OUTPATIENT THERAPY: It is therefore crucial to select the patient group that is suited for an outpatient, antibiotic therapy very carefully. In general only hemodynamically stable patients without complications in whom the responsible organism has been identified should be considered.\nTREATMENT: From a pharmacological point of view intravenous or intramuscular application for the complete duration of therapy is obligatory. Endocarditis caused by penicillin-susceptible streptococci, the biggest group of organisms responsible for endocarditis, can be treated with Ceftriaxon once daily for 4 weeks. For other organisms there are at present no data available which support the feasibility of an outpatient therapy. In particular antibiotic therapy with a complex regimen for those organisms is not practicable for outpatient usage. Possibly, in the near future computer controlled pumps might overcome this disadvantage.\nLIMITS: Every outpatient therapy should be initiated under inpatient conditions and only after an initial response to the antibiotic therapy continued in an outpatient setting. Today reliable outpatient therapy and follow-up 7 days a week under the given outpatient infrastructure is problematic and remains an exception. However, considering cost-effectiveness outpatient as compared to inpatient antibiotic therapy could be an interesting economically advantageous alternative.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/pl00002045", 
    "inLanguage": [
      "de"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1087175", 
        "issn": [
          "0340-9937", 
          "1615-6692"
        ], 
        "name": "Herz", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "name": "M\u00f6glichkeiten und Grenzen einer ambulanten Antibiotikatherapie der infekti\u00f6sen Endokarditis", 
    "pagination": "418-423", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "23a7b34d1296cebb61622a82c8dfd843e168a74b3e2e83368e2677b197535524"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11683072"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7801231"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/pl00002045"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007485680"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/pl00002045", 
      "https://app.dimensions.ai/details/publication/pub.1007485680"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/PL00002045"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/pl00002045'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/pl00002045'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/pl00002045'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/pl00002045'


 

This table displays all metadata directly associated to this object as RDF triples.

140 TRIPLES      20 PREDICATES      44 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/pl00002045 schema:about N0aa5155a5f944fd6b629968b815170bb
2 N1bcb58302f014196852843e988b09075
3 N1f2eac5db8b24ceba477e09defcb6915
4 N23844bdaa9014dc9a1b0dae1d2322ff1
5 N293c320c76f34e859f7e2870811a0077
6 N2d33dd94f03849ccb3e1285fb3a78247
7 N3bee60e3d15c456db3acde4a39588335
8 N3c27f87aa06a42789fea6f46fb8e65a9
9 N48bb9e7c98684321b6040b20061ca69c
10 N5e13ce1b6e594a349aedb74dbbe4259f
11 N8c0081ce94c74f62be0ae8120629a38e
12 Nb370e899da124892b9bcffb27b5bbea2
13 Ne35af2f7a0534323af2bfc7b9409c533
14 Nec32dda007b74d9bb92a5161d854a49f
15 Nf1b0a654bda2472ebda1b78c3bbac72d
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Ndb0926d659eb4e7bb53440045296c4e2
19 schema:datePublished 2001-09
20 schema:datePublishedReg 2001-09-01
21 schema:description BACKGROUND: Infective endocarditis has a high morbidity and lethality. Therefore antibiotic treatment has to be intravenous to achieve high blood levels and has to last several weeks without an interruption of treatment at the weekends. PATIENT SELECTION FOR OUTPATIENT THERAPY: It is therefore crucial to select the patient group that is suited for an outpatient, antibiotic therapy very carefully. In general only hemodynamically stable patients without complications in whom the responsible organism has been identified should be considered. TREATMENT: From a pharmacological point of view intravenous or intramuscular application for the complete duration of therapy is obligatory. Endocarditis caused by penicillin-susceptible streptococci, the biggest group of organisms responsible for endocarditis, can be treated with Ceftriaxon once daily for 4 weeks. For other organisms there are at present no data available which support the feasibility of an outpatient therapy. In particular antibiotic therapy with a complex regimen for those organisms is not practicable for outpatient usage. Possibly, in the near future computer controlled pumps might overcome this disadvantage. LIMITS: Every outpatient therapy should be initiated under inpatient conditions and only after an initial response to the antibiotic therapy continued in an outpatient setting. Today reliable outpatient therapy and follow-up 7 days a week under the given outpatient infrastructure is problematic and remains an exception. However, considering cost-effectiveness outpatient as compared to inpatient antibiotic therapy could be an interesting economically advantageous alternative.
22 schema:genre research_article
23 schema:inLanguage de
24 schema:isAccessibleForFree false
25 schema:isPartOf Ndbe6982cb5e14b1eaf477ef590fba0d6
26 Ne7a38992b6bc43f1bb850abf96072d48
27 sg:journal.1087175
28 schema:name Möglichkeiten und Grenzen einer ambulanten Antibiotikatherapie der infektiösen Endokarditis
29 schema:pagination 418-423
30 schema:productId N323da5aa65304688be2305cd190ca047
31 N580faa258d8e4cf4b60f989d23b70946
32 N68db94f6d4564576a729ac2b8da5561a
33 N863307d3f9c74f6483cfea92ebe4286e
34 Nb8a9654bb25d43c69b45c53e81dd0a4f
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007485680
36 https://doi.org/10.1007/pl00002045
37 schema:sdDatePublished 2019-04-10T19:50
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher Nc0a0e8e309494e50b87d95416d4b2a7a
40 schema:url http://link.springer.com/10.1007/PL00002045
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N0aa5155a5f944fd6b629968b815170bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Patient Compliance
46 rdf:type schema:DefinedTerm
47 N1bcb58302f014196852843e988b09075 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
48 schema:name Humans
49 rdf:type schema:DefinedTerm
50 N1f2eac5db8b24ceba477e09defcb6915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
51 schema:name Anti-Bacterial Agents
52 rdf:type schema:DefinedTerm
53 N1f7c980c37cb4c4ba9cb2fbb44277845 schema:name Klinik für Innere Medizin – Kardiologie, Herzzentrum der Philipps-Universität Marburg, DE
54 rdf:type schema:Organization
55 N23844bdaa9014dc9a1b0dae1d2322ff1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Follow-Up Studies
57 rdf:type schema:DefinedTerm
58 N279ead74ed3b4e729cf38984ce69f19d rdf:first sg:person.0630132362.75
59 rdf:rest rdf:nil
60 N293c320c76f34e859f7e2870811a0077 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Adult
62 rdf:type schema:DefinedTerm
63 N2d33dd94f03849ccb3e1285fb3a78247 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Time Factors
65 rdf:type schema:DefinedTerm
66 N323da5aa65304688be2305cd190ca047 schema:name nlm_unique_id
67 schema:value 7801231
68 rdf:type schema:PropertyValue
69 N3bee60e3d15c456db3acde4a39588335 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Injections, Intravenous
71 rdf:type schema:DefinedTerm
72 N3c27f87aa06a42789fea6f46fb8e65a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Echocardiography
74 rdf:type schema:DefinedTerm
75 N48bb9e7c98684321b6040b20061ca69c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Cephalosporins
77 rdf:type schema:DefinedTerm
78 N580faa258d8e4cf4b60f989d23b70946 schema:name readcube_id
79 schema:value 23a7b34d1296cebb61622a82c8dfd843e168a74b3e2e83368e2677b197535524
80 rdf:type schema:PropertyValue
81 N5e13ce1b6e594a349aedb74dbbe4259f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Patient Selection
83 rdf:type schema:DefinedTerm
84 N68db94f6d4564576a729ac2b8da5561a schema:name doi
85 schema:value 10.1007/pl00002045
86 rdf:type schema:PropertyValue
87 N863307d3f9c74f6483cfea92ebe4286e schema:name dimensions_id
88 schema:value pub.1007485680
89 rdf:type schema:PropertyValue
90 N8c0081ce94c74f62be0ae8120629a38e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Endocarditis, Bacterial
92 rdf:type schema:DefinedTerm
93 N9729790b1a194d34b501049cae5b39eb rdf:first sg:person.01065373312.37
94 rdf:rest N279ead74ed3b4e729cf38984ce69f19d
95 Nb370e899da124892b9bcffb27b5bbea2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Ceftriaxone
97 rdf:type schema:DefinedTerm
98 Nb8a9654bb25d43c69b45c53e81dd0a4f schema:name pubmed_id
99 schema:value 11683072
100 rdf:type schema:PropertyValue
101 Nc0a0e8e309494e50b87d95416d4b2a7a schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 Ndb0926d659eb4e7bb53440045296c4e2 rdf:first sg:person.0700231510.25
104 rdf:rest N9729790b1a194d34b501049cae5b39eb
105 Ndbe6982cb5e14b1eaf477ef590fba0d6 schema:issueNumber 6
106 rdf:type schema:PublicationIssue
107 Ne35af2f7a0534323af2bfc7b9409c533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Streptococcal Infections
109 rdf:type schema:DefinedTerm
110 Ne7a38992b6bc43f1bb850abf96072d48 schema:volumeNumber 26
111 rdf:type schema:PublicationVolume
112 Nec32dda007b74d9bb92a5161d854a49f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Injections, Intramuscular
114 rdf:type schema:DefinedTerm
115 Nf1b0a654bda2472ebda1b78c3bbac72d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Outpatients
117 rdf:type schema:DefinedTerm
118 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
119 schema:name Medical and Health Sciences
120 rdf:type schema:DefinedTerm
121 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
122 schema:name Clinical Sciences
123 rdf:type schema:DefinedTerm
124 sg:journal.1087175 schema:issn 0340-9937
125 1615-6692
126 schema:name Herz
127 rdf:type schema:Periodical
128 sg:person.01065373312.37 schema:familyName Alter
129 schema:givenName Peter
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065373312.37
131 rdf:type schema:Person
132 sg:person.0630132362.75 schema:affiliation N1f7c980c37cb4c4ba9cb2fbb44277845
133 schema:familyName Maisch
134 schema:givenName Bernhard
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630132362.75
136 rdf:type schema:Person
137 sg:person.0700231510.25 schema:familyName Ritter
138 schema:givenName Michael
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700231510.25
140 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...